Skip to main content

Influenza B Native Protein

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-62467

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-62467

Key Product Details

Conjugate

Unconjugated

Applications

ELISA

Product Specifications

Description

Native influenza B antigen. Influenza B, strain Hong Kong 5/72, cultured in MDCK cells.

Source:Virus

Purity

Concentrated Supernatant

Application Notes

Activity: 40960 HA units/ml as determined by hemagglutination endpoint assay.

Protein / Peptide Type

Native Protein

Formulation, Preparation and Storage

NBP2-62467
Preparation Method Clarified and concentrated cell culture supernatant. The antigen preparation is inactivated by gamma radiation.
Formulation Eagle's Minimum Essential Medium
Preservative No Preservative
Concentration 1.75 mg/ml
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store at -70C. Avoid freeze-thaw cycles.

Background: Influenza B

Influenza A and B are the two types of influenza viruses that cause epidemic human disease. Influenza B viruses currently circulating are divided into two antigenically and genetically distinct groups: the Victoria and Yamagata lineages.

Alternate Names

Influenza B Virus NP; NP; Nucleoprotein

Additional Influenza B Products

Product Documents for Influenza B Native Protein

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for Influenza B Native Protein

This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...